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Human c-fus cDNA was transfecled into normal rat liver epithclial (REL) cells to identify cellular modifications associated with high cxprcssion 
oft-Fos protein. Responses to EGF and TGFP were examined i&l the different ccl1 lines, under anchoragedepcndcnt and -independent conditions. 
Scnsiiivity to both factors was modified in trlrnsrectcd cells. While parenial cells in monolayer did not respond to EGF. c-j&containing cells growth 
was stimulutcd by this factor. Overexpression of c-Foe prolein led 10 an enhunccd TGFj-induced growth inhibition under anchorage dependent 
conditions, and TGFD ubolished spontaneous growth in sol‘l ngar of the ccl1 lines containing c-fos oncogenc. The mechanisms underlying the 
increased sensitivity to TCiFfi in c-Ji,.s iransfecied cells arc still to be de~ermincd. 
c-j&; TGF/3; EGF; Rot liver epithclial ccl1 
1. INTRODUCTION 
Expression of c-fos is observed at low or undeluctable 
levels in most exponentially growing cells although ii 
can be activated transiently in response to numerous 
stimuli including growth and serum factors (for review 
see [I]). The c-fos gene seems to be involved in the 
regulation of the normal cell cycle [2] and differentiation 
[3]. This gene encodes a labile 55 kDa phosphorylated 
protein localized in the cell nucleus and likely acting as 
a transcriptional regulator in association with the mem- 
bers of the jL(n family in the APl complex [4]. 
To investigate the intervent.ion of c-Fos protein in 
phenotypic transformation and identify the biological 
modifications associated with a high expression of the 
onto-protein, we transfected human c-J& cDNA into a 
clone of rat liver epithelial (REL) cells. 
Responsiveness to growth factors was examined in 
the different cell lines. We chose to focus on two growth 
factors: epidermal growth factor (EGF) and transform- 
ing growth factor p (TGF/3). EGF, mitogenic for most 
cell types, has been shown to display complex effect in 
REL cell cultures [5]. TGFfi has been found to be a 
potent inhibitor of the in vitro growth of a variety of 
epithelial cells including mammary epithelial cells [G], 
liver epithelial cells [7] and keratinocytes [S]. The TGFfi 
group includes at least three highly homologous genes 
(TGF/31, TGF,62, TGFp3) present in humans and other 
mammals, with additional genes present in avian and 
amphibian genomes [9,10]. All TGF;6 forms tested dis- 
play inhibitory activity in epithelial cell proliferation 
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and mesenchymal differentiation but the various 
isoforms of TGF/3 are multifunctional and their pri- 
mary functions are not yet known [l I]. However, the 
fact that most cells examined possess functionally ac- 
tive, high affmity cell surface receptors for TGFB im- 
plies a fundamental role for this protein in normal cell 
physiology [ll]. TGF/3 has rltised increasing interest 
recently, as it has been suggested that acquisition of 
resistance to growth inhibitors could be a primary event 
in carcinogenesis [ 121. 
The present report describes the modifications noted 
in the c-fis containing cell lines. 
2. MATERIALS AND METHODS 
EGF and TGFP! were obtained from Sigma (France). Restriction 
enzymes were from Bochringer-Maiinheim (Mcylan, France). 
The rat liver cpitheliul (REL) ccl1 culture used in ihcse studies was 
titablishcd from normal rdt liver, a5 described previously [I 3.141. REL. 
cells were grown in Ham’s FlO medium conlainint: 108 fetal catf 
strum (FCS) and antibiotics at 37°C in a humidified utmosphcrc 
containing 5% (vfv) CO,. Because Lin et al. [7] have shown that 
sensitivity of RELC to TGF;B dccrcascs with increasing passngc of 
RELC in culture, all ccl1 lines were tested for TGFP responsiveness 
at similar pnssngc number and up until 28th passage. Low-passage of 
rat liver epitheliul cells (RELC) were tr;msfccted by using the calcium 
phosphate precipi~atc method [IS] with the pM43.1 plasmid [Ifi], a 
generous gilI from M. Piechsczyk (URA CNKS 1191 - France). This 
plasmid was constructed by cloning a ncarir hii-icngth human C-/OS 
cDNA into the BUUIW! site of the pZ!P nco SV(X) rclroviral vector 
[ 171. Neomycin-resistant dones were sclecied in the presence of 600 
@ml of G418 (Gibco-BRL. France). 
2.3. Souhm bfor ar&xis 
High-molecular-wcigbt nudcar DNA from REL cells was isolated 
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as described by f,!8]. DNA (10 pg) was incubated with 50 units of 
EcoRI for 20 h at 37°C. The digested DNAs were clectrophoresed 
through a 1% ag~ose gel and transferred to a nylon filter (Amer- 
sham). Hybridization with the 940 bp &r~~liI-&uI restriction Bag 
ment of the humun c-Jos EDNA radiolabcled by the multiprime DNA 
labcling system (Amershnm) was carried out at 42OC us described by 
[19]. The specific activity of this probe was approximately I x IO” 
cpml&. After a 20 h period of hybridization, filters were wnshcd three 
times in 2 x SSPE (I x SSPE is 0.13 M NuC!. 20 mM NoHzPO.,. 10 
mM EDTA pH 7.4) at room temperature for 5 min and once succcs. 
sively in I x SSPE, 0.5 x SSYE. 0.1 x SSPE at 65’C for 30 min. 
Autorad;ogrtphy was carried out at -8OOC with intensifying screens 
(Philips Universal). 
were pipetted onto a 2 ml base layer (conmining 0.4% agar in Ham’s 
FIO supplemented with FCS 5%) in 35 mm Petri dishes. Plates were 
incubated ut 37OC for I4 days and culonies larger than 50pm were 
scored as positive. 
3. RESULTS 
Total cellulnr RNA was extructed from confluent cultures by the 
gunnidine isothiocyanate procedure [20] followed by ccntrifugation 
over CsCl gradients 1211. For Northern blot analysis. RNA species (25 
erg) were separated on n 1% a&rose gel containing 2.2 M formaIde. 
hyde and then transferred to Hybon nylon mcmbruncs (Amersham) 
for hybridization with JzP-lnbeled Bur~rHl-,lpul restriction fmgment 
of human c-J0.s cDNA. Hybridizution and washing were carried out 
us dc3cribed above. 
After transfection of REL cells with the plasmid 
pM43.1 carrying the human c-fos cDNA and G418- 
resistance gene, and selection with G418, three surviv- 
ing colonies were obtained. These colonies were isolated 
and characterized. Because they presented similar char- 
acteristics, only the 43C clone will be described in this 
paper. No G418-resistant clones arose from untrans- 
fccted REL sells, and the control REL cells, transfected 
with the plasmid pZIP neo U(X) containing the G418 
resistance gene alone [ 171, was not affected in morphol- 
ogy and growth. 
Nuclear extracts from tmnsfectcd, parental or control REL cells 
were prcpurcd essentially as described by [22]. Western blotting and 
immunodectection of Fos were carried out according to [23]. The 
highly specific anti-Fos antibody, used in this study, was a kind Sift 
from Dr. B. Verricr (U 103 CNRS-BioMerieux, France). 
Cells were plated at 70 000 cells135 mm culturedish (Falcon plastics) 
in Ham’s FIO supplemented with 10% FCS and allowed to uttach 
overnight. Following attachment, cultures were washed twice and 
incubated overnight in serum-free medium. Then, media were replaced 
with serum supplemented medium containing various concentrations 
of TGF$?. The inhibition of growth by TGFfi wus usscsscd by cell 
counting using a coultcr cell counter. 
The integration of the c-fos oncogene in the efbs 
transfected REL cells (43C) was demonstrated by 
Southern blot analysis (Fig. 1A). The 23 kb, 12 kb and 
9 kb EcoRl restriction fragments observed in transfec- 
tant were absent from parental cell DNA. The constitu- 
tive expression of the pM43.1 derived mRNA was de- 
tected by Northern blot in 43C only (Fig. 15). Finally, 
the integrity and the nuclear localization of the c-Fos 
protein was confirmed by Western blot analysis (Fig. 
1C). The pattern obtained with 43C nuclear extract was 
similar to the one obtained from serum stimulated Ltk- 
cells, used as control [lG]. 
For the soft agur assays. one ml of cell suspension (5 x IO%nl) in 
0.28% a&r (FMC Rioproducls. USA) in Ham’s FIO containing 5% 
FCS and additionnl growth factors(EGF 7 nglml and TGF/?: 2 n&nl) 
The morphology of 43C was unchanged, compared 
to control and parental REL cells. Nevertheless, cell 
proliferation was markedly increased in 43C cells and 
this line formed colonies in soft agar in the presence of 
5% FCS alone (Fig. 3). 
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Fig. I. Southern blotting analysis of c-for Sent (A), expression of pM43.1 RNA(B) and c-Fos protein (C). A. DNAs (2Opg) extracted from parental 
and c-fox transfected cells were disystcd by EcoRl. Lambda pllsgc DNA i-(indIII and PhiX DNA Hrrelll generated fragments were used as 
molecular weight markers in kilobases. B. Expression of pM43.l RNA in 43C line was reveled with ‘?P-labeled human fragment of c-fos cDNA 
(see [l6]). Positions of2SS and 18s rRNAs are shown and equal amounts of total RNAs were loaded on tiller when stained with cthidium bromide. 
Arrow indicates pM43-I mRNA. C. Expression of human c-Fos protein in 43C is similar to the pattern of c-Fos protein expression in serum- 
stimulated Ltk- cells used hcrc as control. No c-Fos expression is detectable in parcnml cells, The positions of prestained molcculur size markers 
are shown on the right. 
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Fig. 2. Monolayer growth. (1) TGFfi dose-response: growth inhibition purcenlage of parental cells (0) and 43C cclks (A) in presence of different 
concentrations ofTGF/3 (~.~~~.05/~.l/O.2/0.5/1~2 &ml). (2) EGF and TGF,8 kinetic curves. (@) pnrcntal cells, (A)43C cellr. Eachassay paint was 
pcrforlned in triplicate in whid the values differed by no more than 3.4%. 
Parental and transfected REL celis were examined for caused a dose-dependent inhibition of cell proliferation 
responsiveness togrowth inhibition induced by TGFJI. which reached a maximum of 30%. The c-fos containing 
Fig. 2.1 and Fig. 2.2 illustrate representative TGFP cell line (43C) seemed twice as sensitive to the TGFj3 
dose-response and kinetic curves under nnchorage-de- than the parental cells. Indeed, the inhibition observed 
pendent conditions and Fig. 3 summarizes the effects of in 43C cell cultures was higher (57%) in monolayer 
TGFj? treatment on colony formation in soft agar gro..~~th (Fig. 2.1) and arose with a shorter latency pe- 
assay. Treatment with TGFj? of parental REL cells rio.! in 43C cells (24 h) than in parental REL cells (48 
80 
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Fi&. 3. Anchorage independent growth in soft agnr of pnrental tills (not transfecteci cells), control cells (tnnsfectcd with il plusmid containing the 
G418 resistance gene alone) and 43C cells (c-$x transfected cells) in prescncc of gowth factors at the indioaied concentration. Each vnluc is the 
mean of triplicate dishes. 
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h) (Fig. 2.2). Moreover, the colony formation in soft 
agar was completely abolished in c-fos transfectcd line 
by 2 r&ml of TGF/3 (Fig. 3). 
Tsao et al. have shown that the in vitro proliferation 
of normal REL cells may be either inhibited or stimu- 
lated by EGF depending on the passage number, and 
that the effect of growth modulators on the prolifera- 
tion of REL cells may be altered by the extracellular 
substrate on or in which they grow [S]. Therefore, we 
also studied the effect of EGF (with or without TGF,@ 
on cell growth in monolayer and in soft agar. While 
anchorage-dependent growth was increased only in 43C 
cells by EGF and remained unchanged in control or 
parental cells (Fig. 2), in soft agar assay, all cell lines 
were stimulated by EGF and presented significant col- 
ony formation (Fig. 3). 
TGFB at 2 &ml inhibited the EGF-induced colony 
formation in all the REL cell lines. 
4. DlSCUSSION 
We have established arat epithelial iver cell line (43C 
line) producing a constitutive expression of protein en- 
coded by the human c-fos cDNA. The cDNA was tran- 
scribed into a single mRNA species of 6 kb which corre- 
sponds to the genomic pM43.1 RNA [16]. The c-Fos 
protein was detected in the nucleus and the pattern 
obtained with 43C was similar to that of serum stimu- 
lated Ltk’ cells used as control [16]. 
The proliferation of c-fos transfected cells (43C) was 
increased comparatively to the parental REL cells and, 
in the presence of EGF, only the 43C cells exhibited an 
enhanced growth rate. It has been shown that prolifera- 
tion of early passage of REL cells in anchorage-depend- 
ent conditions was inhibited by EGF [S]. Moreover, it 
was demonstrated that these cell lines contain a hetero- 
geneous population of cells which responded ifferently 
to EGF and in particular, a small fraction of this heter- 
ogeneous population resisted this effect and was stimu- 
lated by this treatment [S]. In our study, the prolifera- 
tion of the parental ine was not affected by EGF. This 
may be due to the fact thaL the parental cell line was a 
clonally derived cell-strain, and therefore a homogene- 
ous population in which the phenotype of EGF-induced 
growth inhibition was diminished. In opposite, the 43C 
cell line transfected with c-fos was sensitized to anchor- 
age-dependent growth stimulation by EGF. Thus, cells 
that contain an activated c-j& oncogene seemed to ex- 
hibit an increased sensitivity to the growth-promoting 
activity of normal growth factor, EGF, and respond to 
it in a qualitatively different manner than the parental 
C&i. 
In contrast, in soft agar culture, parental and c-10s 
transfected REL cell lines presented colony formation 
in presence of EGF. Whereas c-J& containing cell 
growth was stimulated by EGF regardless of the an- 
4c2 
chorage dependency, control or parental cells re- 
sponded differently to EGF, depending on the culture 
conditions. EGF action on REL cell cultures is complex 
and highly variable. Similar findings with retinoic acid 
have also been reported in rat epithelial cell lines [24]. 
It has been suggested that acquisition of resistance to 
normal growth inhibitors might well be the primary 
event in carcinogenesis or at least a necessary event 
occurring later in the process [12]. Indeed, although 
anchorage dependent growth of most normal epithelial 
cells was inhibired by TGFP, many transformed epithe- 
lial cell lines were resistant to this inhibitory effect 
125,261. 
Our results demonstrated that the introduction of a 
human c-j& cDNA into REL cells led to an increased 
sensitivity to the growth inhibitory effects of TGF/3 
under both anchorage dependent and independent con- 
ditions. On the other hand, the results of the soft agar 
assay clearly showed that transfected cells were partially 
transformed since they showed significant colony for- 
mation in the presence of 5% FCS [27]. Many studies 
have reported a resistance to TGFP in transformed cells 
[26], but our results are not necessarily inconsistent with 
the theory that resistance to growth inhibitory factor is 
an important and/or obligate event during carcinogene- 
sis [12]. c-Fos protein is known to be a pleiotropic pro- 
tein acting as both a transrepressor and a transactivator 
of transcription [25]. In light of our data, one could 
speculate on a direct action of the oncoprotein on the 
synthesis of TGF/? or its receptor, or on a postreceptor 
mechanism intensifying the response to TGFB. Further 
work needs to be done to determine the mechanisms 
underlying the increased sensitivity to this growth factor 
in C-/OS transfected REL cells. 
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